⏱ 1 min read
Commercially licensed drivers and other transportation employees will continue to face sanctions for their use of state-authorized medical cannabis products, according to recently issued guidance from the US Department of Transportation. The memo, dated May 26, affirms that there has been no change in drug testing-related policy despite the Justice Department’s decision to reclassify state-approved medical cannabis from Schedule I to Schedule III of the Controlled Substances Act. “Marijuana use under state marijuana programs or…
Explore all articles: CBD and hemp products
